Pomezia, Italy

Sonia Covaceuszach

This inventor holds 1 USPTO granted patent. Top assignees: Pangenetics B.v., Scoula Internazionale Superiore Di Studi Avanzati. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sonia Covaceuszach. Retrieved from https://idiyas.com/inventor/sonia-covaceuszach-2hyoeids

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sonia Covaceuszach: Innovator in Antibody Humanization

Introduction

Sonia Covaceuszach is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of biotechnology, particularly in the humanization of antibodies. Her innovative methods have the potential to enhance therapeutic applications in medicine.

Latest Patents

Sonia holds a patent for a "Method for the humanization of antibodies and humanized antibodies thereby obtained." This method focuses on the humanization of the VH and VL variable regions of an animal antibody of known sequence. The patent specifically addresses the creation of humanized animal antibodies, including anti-NGF and anti-TrkA humanized animal antibodies. She has 1 patent to her name.

Career Highlights

Throughout her career, Sonia has worked with notable organizations, including the Scuola Internazionale Superiore Di Studi Avanzati and Pangenetics B.V. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Sonia has collaborated with esteemed colleagues such as Antonino Cattaneo and Doriano Lamba. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Sonia Covaceuszach is a trailblazer in the field of antibody humanization, with a focus on developing methods that can significantly impact therapeutic practices. Her contributions and collaborations continue to shape the future of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…